Skip to content

A Study to Determine the Role of Physician Gestalt in Predicting COVID-19 in Patients

A Prospective Observational Study to Determine the Role of Physician Gestalt in Clinical Prediction of COVID-19

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04974177
Enrollment
876
Registered
2021-07-23
Start date
2021-03-15
Completion date
2022-09-15
Last updated
2024-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

All Patients Undergoing COVID 19 Specific Testing

Brief summary

THIS IS A PROSPECTIVE OBSERVATIONAL STUDY TO DETERMINE THE ROLE OF PHYSICIAN GESTALT IN CLINICAL PREDICTION OF COVID 19.

Detailed description

Among patients attending the Emergency Department, prompt identification of possible cases of COVID 19 is important to avoid the spread. An immediate clinical diagnosis is important for point of care decision making on choice of treatment facility as well as for triaging, testing and to quarantine patients admitted to the hospital from emergency room. Hence this study attempts to find out the role of physician gestalt in early diagnosis and differentiation of COVID 19.

Interventions

None listed

Sponsors

Jubilee Mission Medical College and Research Institute
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* All patients presenting to ED, who undergo COVID 19 specific testing.

Exclusion criteria

* Patients with active COVID 19 disease diagnosed outside All brought dead cases. All patients not consenting to take part in the study.

Design outcomes

Primary

MeasureTime frame
Sensitivity, specificity, positive and negative likelihood ratio of physician gestalt in diagnosis of COVID 19 in patients presenting to ED who are being sent for COVID 19 specific testing.march 2021- september 2022

Secondary

MeasureTime frame
Sensitivity, specificity, positive and negative likelihood ratio of clinical and epidemiological variables in patients presenting to ED who are being sent for COVID 19 specific testing.march 2021- september 2022

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026